Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy
Conditions
- Astrocytoma, IDH-Mutant
- Glioblastoma
- Glioma
- Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted
Interventions
- BEHAVIORAL: Assessment
- OTHER: Questionnaire Administration
- OTHER: Telemedicine Visit
- DRUG: Temozolomide
Sponsor
Mayo Clinic